• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

小肠药物吸收模型:我们现状如何,又将走向何方?

Models for drug absorption from the small intestine: where are we and where are we going?

作者信息

Billat Pierre-André, Roger Emilie, Faure Sébastien, Lagarce Frédéric

机构信息

MINT, UNIV Angers, INSERM 1066, CNRS 6021, Université Bretagne Loire, France.

MINT, UNIV Angers, INSERM 1066, CNRS 6021, Université Bretagne Loire, France; Pharmacy Department, Angers University Hospital, Angers, France.

出版信息

Drug Discov Today. 2017 May;22(5):761-775. doi: 10.1016/j.drudis.2017.01.007. Epub 2017 Jan 20.

DOI:10.1016/j.drudis.2017.01.007
PMID:28115264
Abstract

The small intestine is a complex organ with movements, flora, mucus and flows. Despite this, the most widely used absorption models consider the organ a cylindrical monoepithelial tube. This review presents the recent evolution of models to take into consideration the complex nature of gut physiology. The most commonly encountered issues are ethical (in vivo models) and differences in drug transport as a result of a modified expression of drug transporters or metabolic enzymes compared with human (in vitro and in vivo models). Finally, this review discusses the way forward to reach an ideal equilibrium between reproducibility, predictability and efficiency for predicting permeability. The features of an ideal model are listed as a guideline for future development.

摘要

小肠是一个具有蠕动、菌群、黏液和流体的复杂器官。尽管如此,最广泛使用的吸收模型将该器官视为圆柱形单上皮管。本综述介绍了模型的最新进展,以考虑肠道生理学的复杂性质。最常见的问题是伦理问题(体内模型)以及与人类相比,由于药物转运体或代谢酶表达改变导致的药物转运差异(体外和体内模型)。最后,本综述讨论了在预测通透性的可重复性、可预测性和效率之间达到理想平衡的前进方向。列出了理想模型的特征作为未来发展的指导方针。

相似文献

1
Models for drug absorption from the small intestine: where are we and where are we going?小肠药物吸收模型:我们现状如何,又将走向何方?
Drug Discov Today. 2017 May;22(5):761-775. doi: 10.1016/j.drudis.2017.01.007. Epub 2017 Jan 20.
2
Application of the MechPeff model to predict passive effective intestinal permeability in the different regions of the rodent small intestine and colon.应用MechPeff模型预测啮齿动物小肠和结肠不同区域的被动有效肠道通透性。
Biopharm Drug Dispos. 2017 Mar;38(2):94-114. doi: 10.1002/bdd.2072.
3
Segmental dependent transport of low permeability compounds along the small intestine due to P-glycoprotein: the role of efflux transport in the oral absorption of BCS class III drugs.由于P-糖蛋白导致低渗透性化合物沿小肠的节段依赖性转运:外排转运在BCS III类药物口服吸收中的作用
Mol Pharm. 2009 Jan-Feb;6(1):19-28. doi: 10.1021/mp800088f.
4
Localisation of drug permeability along the rat small intestine, using markers of the paracellular, transcellular and some transporter routes.利用细胞旁、跨细胞及一些转运途径的标志物对大鼠小肠药物渗透性进行定位。
Eur J Pharm Sci. 2004 Dec;23(4-5):385-91. doi: 10.1016/j.ejps.2004.09.002.
5
Closed-Loop Doluisio (Colon, Small Intestine) and Single-Pass Intestinal Perfusion (Colon, Jejunum) in Rat-Biophysical Model and Predictions Based on Caco-2.大鼠闭环扩散(结肠、小肠)和单通道肠道灌注(结肠、空肠)——基于Caco-2细胞的生物物理模型及预测
Pharm Res. 2017 Dec 29;35(1):2. doi: 10.1007/s11095-017-2331-z.
6
Methodology for development of a physiological model incorporating CYP3A and P-glycoprotein for the prediction of intestinal drug absorption.构建包含CYP3A和P-糖蛋白的生理模型以预测肠道药物吸收的方法学。
J Pharm Sci. 2009 Jun;98(6):2180-97. doi: 10.1002/jps.21572.
7
Why is it challenging to predict intestinal drug absorption and oral bioavailability in human using rat model.为何利用大鼠模型预测人体肠道药物吸收和口服生物利用度具有挑战性?
Pharm Res. 2006 Aug;23(8):1675-86. doi: 10.1007/s11095-006-9041-2.
8
PBPK models for the prediction of in vivo performance of oral dosage forms.用于预测口服剂型体内性能的生理药代动力学(PBPK)模型。
Eur J Pharm Sci. 2014 Jun 16;57:300-21. doi: 10.1016/j.ejps.2013.09.008. Epub 2013 Sep 21.
9
[Drug metabolism in the small intestine--the significance for biological availability].[小肠中的药物代谢——对生物利用度的意义]
Ugeskr Laeger. 2000 May 29;162(22):3215-9.
10
Prediction of intestinal first-pass drug metabolism.肠道首过药物代谢的预测。
Curr Drug Metab. 2007 Oct;8(7):676-84. doi: 10.2174/138920007782109733.

引用本文的文献

1
Comparison of new secondgeneration H1 receptor blockers with some molecules; a study involving DFT, molecular docking, ADMET, biological target and activity.新型第二代H1受体阻滞剂与某些分子的比较;一项涉及密度泛函理论(DFT)、分子对接、药物代谢动力学(ADMET)、生物靶点及活性的研究。
BMC Chem. 2025 Jan 4;19(1):4. doi: 10.1186/s13065-024-01371-4.
2
Variation in human gut microbiota impacts tamoxifen pharmacokinetics.人类肠道微生物群的变化会影响他莫昔芬的药代动力学。
mBio. 2025 Jan 8;16(1):e0167924. doi: 10.1128/mbio.01679-24. Epub 2024 Nov 25.
3
Enteroids to Study Pediatric Intestinal Drug Transport.
肠类器官用于研究儿科肠道药物转运
Mol Pharm. 2024 Oct 7;21(10):4983-4994. doi: 10.1021/acs.molpharmaceut.4c00339. Epub 2024 Sep 16.
4
Enhancing Oral Delivery of Biologics: A Non-Competitive and Cross-Reactive Anti-Leptin Receptor Nanofitin Demonstrates a Gut-Crossing Capacity in an Ex Vivo Porcine Intestinal Model.增强生物制剂的口服递送:一种非竞争性且具有交叉反应性的抗瘦素受体纳米适配体在离体猪肠道模型中展现出肠道穿透能力。
Pharmaceutics. 2024 Jan 16;16(1):116. doi: 10.3390/pharmaceutics16010116.
5
Improving ADMET Prediction Accuracy for Candidate Drugs: Factors to Consider in QSPR Modeling Approaches.提高候选药物的 ADMET 预测准确性:QSPR 建模方法中需要考虑的因素。
Curr Top Med Chem. 2024;24(3):222-242. doi: 10.2174/0115680266280005231207105900.
6
Influence of deoxynivalenol and zearalenone on the immunohistochemical expression of oestrogen receptors and liver enzyme genes in vivo in prepubertal gilts.脱氧雪腐镰刀菌烯醇和玉米赤霉烯酮对未成年小母猪体内雌激素受体和肝酶基因免疫组织化学表达的影响。
Arch Toxicol. 2023 Aug;97(8):2155-2168. doi: 10.1007/s00204-023-03502-7. Epub 2023 Jun 16.
7
Development of physiologically-based gut absorption model for probabilistic prediction of environmental chemical bioavailability.开发基于生理学的肠道吸收模型,用于概率预测环境化学物质的生物利用度。
ALTEX. 2023;40(3):471-484. doi: 10.14573/altex.2210031. Epub 2023 May 3.
8
Montmorillonite-Rifampicin Nanohybrid for pH-Responsive Release of the Tuberculostatic.用于pH响应性释放抗结核药物的蒙脱石-利福平纳米杂化物
Pharmaceutics. 2023 Feb 3;15(2):512. doi: 10.3390/pharmaceutics15020512.
9
Development of Lipid Nanoparticles Containing Omega-3-Rich Extract of Microalga .含有富含omega-3的微藻提取物的脂质纳米颗粒的研发
Foods. 2022 Nov 22;11(23):3749. doi: 10.3390/foods11233749.
10
RoboCap: Robotic mucus-clearing capsule for enhanced drug delivery in the gastrointestinal tract.RoboCap:用于增强胃肠道药物输送的机器人黏液清除胶囊。
Sci Robot. 2022 Sep 28;7(70):eabp9066. doi: 10.1126/scirobotics.abp9066.